Notice of interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▼Subject
 16.4.2019GlaxoSmithKline Biologicals S.A. (GAG)45237Cervarix injekčná suspenzia v naplnenej injekčnej striekačke (sus inj 1x0,5 ml (striek.inj.napl.+1ihla))16.4.2019R
 17.4.2019Aspen Pharma Trading Limited (ASE-1)90021Marcaine spinal 0,5 % heavy (sol inj 5x4 ml/20 mg (amp.skl.))17.4.2019R
 17.4.2019LEO Pharma A/S (LEO-2)97639Skinoren krém (crm 1x30 g (tuba Al))18.4.2019R
 30.4.2019Zentiva, k.s. (ZNT-1)5330AEzen 10 mg (tbl 30x10 mg (blis.PVC/Aclar/PVC/Al))18.4.2019O
 16.4.2019IMUNA PHARM, a.s. (IMA)56930IMMODIN (plv iol 1x1 dávka lyof.+1x4 ml solv. (amp.skl.))22.4.2019R
 26.4.2019KRKA, d.d., Novo mesto (KRK-2)1207BLexaurin 3 mg (tbl 28x3 mg (blis.Al/PVC))23.4.2019O
 24.4.2019Merck Santé s.a.s (MES)33372Glucophage 1000 mg (tbl flm 120x1000 mg (blister PVC/Al))23.4.2019R
 24.4.2019MERCK spol. s r.o. (MRS)24824Euthyrox 25 mikrogramov (tbl 100x25 µg (blis.PP/Al))23.4.2019R
 23.4.2019Zentiva, k.s. (ZNT-1)01066FRAMYKOIN (ung der 1x10 g (tuba Al))24.4.2019O
 24.4.2019GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)37364Voltaren Emulgel (gel 1x50 g (tuba lamin.LDPE/Al/HDPE))24.4.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)79737Irbesartan Actavis 150 mg (tbl flm 28x150 mg (blis.PVC/PVDC/Al))25.4.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80019Irbesartan Actavis 300 mg (tbl flm 30x300 mg (fľ.HDPE))25.4.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80013Irbesartan Actavis 300 mg (tbl flm 28x300 mg (blis.PVC/PVDC/Al))25.4.2019Z
 25.4.2019MERCK spol. s r.o. (MRS)91954Euthyrox 25 mikrogramov (tbl 100x25 µg (blis.PVC/Al))25.4.2019R
 26.4.2019Mylan Ireland Limited (MNY)47775Ropinirol Mylan 1 mg (tbl flm 84x1 mg (obal HDPE))26.4.2019R

Subject means: R-Break, O-Renew or Z-Cancellation of human drug delivery


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)